Fulflex Acquires 300,000-Square-Foot, Fully Automated Medical Products Manufacturing Facility in Texas

Fulflex has announced the successful acquisition of a 300,000-square-foot medical products manufacturing facility located in Jacksonville, Texas, marking a significant expansion of its North American healthcare manufacturing platform. The deal, finalized on July 10, 2026, adds over 250 employees to Fulflex's global workforce and positions the Jacksonville site as one of the company's largest manufacturing locations worldwide. While the deal value remains undisclosed, it represents a strategic investment in the healthcare manufacturing sector.

The newly acquired facility is fully automated and situated on a 30-acre campus, enhancing Fulflex's capabilities in producing a diverse range of critical medical products utilized by healthcare providers and patients globally. The advanced manufacturing technologies employed at the site include plastics injection molding, blow molding, thermoforming, extrusion, and automated production processes. This acquisition is expected to significantly bolster Fulflex's ability to deliver high-quality, reliable, and scalable manufacturing solutions to its customers.

Fulflex's acquisition aligns with the company's broader strategy to expand its operational footprint and enhance its manufacturing capabilities in polymer processing and medical device manufacturing. The integration of the Jacksonville facility is anticipated to provide Fulflex with increased manufacturing flexibility, improved supply chain resilience, and greater geographic diversity. These enhancements are critical in a sector that is increasingly focused on meeting the demands for high-quality medical products in a timely manner.

The Garware family, which has a long-standing history in manufacturing, aims to build upon the operational foundation established at the Jacksonville site. The company is committed to investing in technology, innovation, and employee development to ensure the facility's success. Diya Garware Ibanez, Chairperson of Fulflex, emphasized the importance of the dedicated workforce in Jacksonville and expressed the company's commitment to fostering a thriving environment for both employees and the local community.

This acquisition comes at a time when the healthcare manufacturing sector is experiencing growth driven by increasing demand for medical products and innovations in manufacturing technologies. As Fulflex integrates the Jacksonville facility into its operations, the company is well-positioned to capitalize on these trends, reinforcing its status as a key player in the global healthcare manufacturing landscape. The successful transition and welcoming of the Jacksonville team into the Fulflex family signal a positive outlook for the company's future endeavors in this vital sector.